Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cooper

Showing results (101-110 of 363) with videos related to

Pageof 37
Sort By:
Clinical and Experimental Immunology|June 1, 1977
The effect of acute and prolonged administration of prednisolone and ACTH on lymphocyte subpopulationsD A Cooper, V Petts, E Luckhurst, et al.
Analytical Chemistry|May 1, 1986
Determination of neutral manufacturing impurities in heroin by capillary gas chromatography with electron capture detection after reduction with lithium aluminum hydride and derivatization with heptafluorobutyric anhydrideJ M Moore, A C Allen, D A Cooper
AIDS (London, England)|May 24, 2001
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapyA Carr, J Miller, J A Eisman, et al.
The Medical Journal of Australia|January 4, 1993
HIV seroconversion illnessM J Boyle, M McMurchie, B Tindall, et al.
Lancet (London, England)|July 4, 1998
Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceA Carr, K Samaras, D J Chisholm, et al.
The Medical Journal of Australia|March 7, 1988
Risks of human immunodeficiency and hepatitis B viral infections in intravenous drug abusersM L McLaws, J McGirr, W Croker, et al.
Australian and New Zealand Journal of Medicine|April 1, 1976
Monitoring immune function during immunosuppressive therapyJ B Ziegler, P Hansen, D A Cooper, et al.
The Journal of Infectious Diseases|June 3, 1999
CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremiaJ Wilkinson, J J Zaunders, A Carr, et al.
The Journal of Infectious Diseases|February 1, 1996
Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavirA D Kelleher, A Carr, J Zaunders, et al.
Applied and Environmental Microbiology|June 1, 1991
Anaerobic biodegradation of cyanide under methanogenic conditionsR D Fallon, D A Cooper, R Speece, et al.
Pageof 37

Showing results (101-110 of 363) with videos related to

Sort By:
Pageof 37
Clinical and Experimental Immunology|June 1, 1977
The effect of acute and prolonged administration of prednisolone and ACTH on lymphocyte subpopulationsD A Cooper, V Petts, E Luckhurst, et al.
Analytical Chemistry|May 1, 1986
Determination of neutral manufacturing impurities in heroin by capillary gas chromatography with electron capture detection after reduction with lithium aluminum hydride and derivatization with heptafluorobutyric anhydrideJ M Moore, A C Allen, D A Cooper
AIDS (London, England)|May 24, 2001
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapyA Carr, J Miller, J A Eisman, et al.
The Medical Journal of Australia|January 4, 1993
HIV seroconversion illnessM J Boyle, M McMurchie, B Tindall, et al.
Lancet (London, England)|July 4, 1998
Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceA Carr, K Samaras, D J Chisholm, et al.
The Medical Journal of Australia|March 7, 1988
Risks of human immunodeficiency and hepatitis B viral infections in intravenous drug abusersM L McLaws, J McGirr, W Croker, et al.
Australian and New Zealand Journal of Medicine|April 1, 1976
Monitoring immune function during immunosuppressive therapyJ B Ziegler, P Hansen, D A Cooper, et al.
The Journal of Infectious Diseases|June 3, 1999
CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremiaJ Wilkinson, J J Zaunders, A Carr, et al.
The Journal of Infectious Diseases|February 1, 1996
Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavirA D Kelleher, A Carr, J Zaunders, et al.
Applied and Environmental Microbiology|June 1, 1991
Anaerobic biodegradation of cyanide under methanogenic conditionsR D Fallon, D A Cooper, R Speece, et al.
Pageof 37